Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017.

ABSTRACT:

Aims

To measure the variation in prescribing of second-line non-insulin diabetes drugs.

Materials and methods

We evaluated time trends for the period 1998 to 2016, using England's publicly available prescribing datasets, and stratified these by the order in which they were prescribed to patients using the Clinical Practice Research Datalink. We calculated the proportion of each class of diabetes drug as a percentage of the total per year. We evaluated geographical variation in prescribing using general practice-level data for the latest 12 months (to August 2017), with aggregation to Clinical Commissioning Groups. We calculated percentiles and ranges, and plotted maps.

Results

Prescribing of therapy after metformin is changing rapidly. Dipeptidyl peptidase-4 (DPP-4) i

SUBMITTER: Curtis HJ 

PROVIDER: S-EPMC6099452 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature